— Know what they know.
/
Not Investment Advice

BLFS NASDAQ

BioLife Solutions, Inc.
1W: -3.1% 1M: +3.8% 3M: +34.2% YTD: +56.1% 1Y: +42.8% 3Y: +165.5% 5Y: -20.5%
$37.30
+0.52 (+1.41%)
 
Weekly Expected Move ±4.1%
$34 $36 $37 $39 $40
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Buy · Power 59 · $1.8B mcap · 43M float · 2.45% daily turnover · Short 27% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
39.3 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 13.2%
Cost Advantage
23
Intangibles
59
Switching Cost
36
Network Effect
33
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BLFS has No discernible competitive edge (39.3/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. ROIC of 13.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$31
Avg Target
$32
High
Based on 8 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 6Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$31.00
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-07-27 Stephens — $30 $31 +1 +3.4% $29.98
2026-07-23 Jefferies Matthew Stanton $22 $31 +9 -0.5% $31.15
2026-07-23 H.C. Wainwright Yi Chen $32 $31 -1 -0.5% $31.15
2026-07-23 William Blair — Initiated $31 — -0.5% $31.15
2026-07-22 Craig-Hallum — $30 $31 +1 -0.5% $31.15
2026-07-22 Lake Street — Initiated $31 — -0.6% $31.20
2026-01-05 Northland Securities — Initiated $34 — +35.3% $25.14
2025-11-24 H.C. Wainwright Yi Chen $30 $32 +2 +20.6% $26.53
2025-03-05 H.C. Wainwright — Initiated $30 — +14.3% $26.25
2024-11-15 Stephens Jacob Johnson Initiated $30 — +39.0% $21.57
2024-08-12 Craig-Hallum Matt Hewitt Initiated $30 — +18.8% $25.25
2024-04-03 Jefferies Matthew Stanton Initiated $22 — +27.0% $17.32

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
1
ROE
4
ROA
5
D/E
2
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BLFS receives an overall rating of B. Strongest factors: ROE (4/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-14 B+ B
2026-08-07 C B+
2026-05-08 C- C
2026-04-01 C C-
2026-03-30 C- C
2026-03-02 C C-
2026-02-26 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 52 Grade B
Profitability
65
Balance Sheet
85
Earnings Quality
48
Growth
77
Value
49
Momentum
71
Safety
100
Cash Flow
6
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BLFS scores highest in Safety (100/100) and lowest in Cash Flow (6/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
30.07
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✗ ✓ ✓ ✗ ✗ ✓
Beneish M-Score
-1.99
Unlikely Manipulator
Ohlson O-Score
-11.35
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 84.5/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: 0.33x
Accruals: 8.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BLFS scores 30.07, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BLFS scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BLFS's score of -1.99 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BLFS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BLFS receives an estimated rating of AA- (score: 84.5/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). BLFS's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
36.07x
PEG
-0.01x
P/S
17.72x
P/B
4.34x
P/FCF
-1539.91x
P/OCF
82.48x
EV/EBITDA
135.49x
EV/Revenue
12.89x
EV/EBIT
213.60x
EV/FCF
-1466.15x
Earnings Yield
3.62%
FCF Yield
-0.06%
Shareholder Yield
0.00%
Graham Number
$14.01
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 36.1x earnings, BLFS commands a growth premium. Graham's intrinsic value formula yields $14.01 per share, 166% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
6.254
NI / EBT
×
Interest Burden
1.300
EBT / EBIT
×
EBIT Margin
0.060
EBIT / Rev
×
Asset Turnover
0.246
Rev / Assets
×
Equity Multiplier
1.088
Assets / Equity
=
ROE
13.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BLFS's ROE of 13.2% is driven by Asset Turnover (0.246), indicating efficient use of assets to generate revenue. A tax burden ratio of 6.25 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$8.70
Price/Value
3.25x
Margin of Safety
-224.65%
Premium
224.65%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with BLFS's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. BLFS trades at a 225% premium to its adjusted intrinsic value of $8.70, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 36.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$37.30
Median 1Y
$33.20
5th Pctile
$11.32
95th Pctile
$97.10
Ann. Volatility
66.0%
Analyst Target
$31.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Roderick de Greef
Chief Executive Officer and Chairman of the Board
 $744,450 $5,571,874 $7,046,205
Troy Wichterman Financial
ancial Officer
 $472,000 $1,820,443 $2,554,007
Aby J. Mathew
Executive Vice President and Chief Scientific Officer
 $435,000 $1,111,511 $1,733,494
Karen Foster Quality
uality and Operations Officer
 $430,000 $901,210 $1,515,139
Garrie Richardson -
Former Chief Revenue Officer
 $317,479 $651,833 $1,387,288
Todd Berard -
Chief Commercial Officer
 $336,373 $630,860 $1,127,495

CEO Pay Ratio

20:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,046,205
Avg Employee Cost (SGA/emp): $357,226
Employees: 155

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
155
-2.5% YoY
Revenue / Employee
$620,735
Rev: $96,214,000
Profit / Employee
$-78,258
NI: $-12,130,000
SGA / Employee
$357,226
Avg labor cost proxy
R&D / Employee
$48,813
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 1.4% -2.4% -4.2% -21.9% -23.4% -32.8% -1.3% -1.2% -27.6% -18.9% -1.7% -2.9% -14.0% -5.9% -3.0% -1.7% -0.9% -3.4% -2.9% 13.2% 13.15%
ROA 1.2% -2.1% -3.7% -19.1% -20.0% -27.7% -29.4% -18.4% -22.7% -15.4% -14.8% -18.2% -11.6% -5.0% -2.6% -1.5% -0.8% -3.0% -2.6% 12.1% 12.09%
ROIC -3.8% -6.3% -8.0% -9.8% -9.4% -8.9% 11.8% 13.7% -11.1% -10.7% -8.3% -5.7% -3.8% -2.1% -1.4% -4.9% -4.4% -3.2% -2.8% 13.2% 13.19%
ROCE -4.7% -6.3% -7.6% -25.3% -24.5% -26.2% -28.0% -10.3% -15.8% -16.1% -13.7% -13.3% -5.4% -0.2% 0.3% -3.7% -3.3% -3.5% -3.2% 1.4% 1.43%
Gross Margin 26.4% 18.4% 32.5% 35.4% 33.7% 31.6% 37.2% 29.9% 50.9% 52.1% 66.4% 67.0% 71.3% -2.4% 65.9% 64.6% 61.4% 67.5% 63.3% 64.2% 64.24%
Operating Margin -33.0% -48.7% -30.3% -21.5% -22.2% -23.1% -34.2% -38.7% -37.1% -42.9% -17.9% -18.6% -5.1% -40.5% -5.1% -65.5% -0.3% 31.0% 0.1% 6.0% 5.96%
Net Margin 0.2% -40.8% -19.5% -1.8% -24.4% -1.1% -36.4% -25.8% -1.2% -77.0% -55.4% -1.1% -5.6% -3.6% -1.9% -62.3% 2.2% 18.8% 4.3% 1.6% 1.58%
EBITDA Margin -21.6% -32.7% -7.7% -1.8% -16.0% -15.3% -25.5% -17.0% -1.1% -60.6% -4.1% 5.4% 2.8% -2.0% 0.7% -56.4% 4.4% 26.1% 2.6% 10.2% 10.23%
FCF Margin -12.7% -11.1% -15.9% -16.4% -16.1% -11.7% -9.5% -7.3% -11.6% -16.0% -17.9% -4.9% 6.6% 7.5% 15.9% 15.0% 14.3% 0.4% -1.8% -0.9% -0.88%
OCF Margin -1.2% -4.1% -10.5% -11.3% -11.2% -5.2% -2.0% -0.7% -4.8% -10.6% -14.4% -0.1% 10.6% 12.9% 20.7% 20.3% 22.8% 20.9% 17.9% 16.4% 16.41%
ROE 3Y Avg snapshot only -4.14%
ROA 3Y Avg snapshot only -3.25%
ROIC 3Y Avg snapshot only -56.12%
ROIC Economic snapshot only 10.75%
Cash ROA snapshot only 3.77%
Cash ROIC snapshot only 4.78%
CROIC snapshot only -0.26%
NOPAT Margin snapshot only 45.34%
Pretax Margin snapshot only 7.84%
R&D / Revenue snapshot only 8.15%
SGA / Revenue snapshot only 53.84%
SBC / Revenue snapshot only 12.63%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 389.19 -185.28 -66.64 -6.19 -9.26 -5.61 -6.44 -11.56 -5.89 -10.96 -13.39 -13.42 -25.12 -61.78 -103.41 -186.18 -387.69 -96.97 -89.52 27.60 36.074
P/S Ratio 18.97 13.04 6.89 3.97 6.27 4.81 5.73 5.92 4.15 6.16 8.52 12.46 13.43 19.10 15.20 13.46 16.80 12.23 9.42 13.54 17.724
P/B Ratio 3.75 3.23 2.00 1.42 2.38 2.14 -3.59 -3.54 1.81 2.16 2.53 3.07 3.55 3.57 3.05 2.97 3.51 3.16 2.52 3.31 4.340
P/FCF -149.28 -117.48 -43.35 -24.19 -39.02 -41.26 -60.37 -80.84 -35.81 -38.58 -47.61 -252.01 204.61 254.27 95.38 89.93 117.68 2827.50 -523.78 -1539.91 -1539.913
P/OCF — — — — — — — — — — — — 127.10 147.90 73.57 66.24 73.79 58.48 52.50 82.48 82.484
EV/EBITDA -126.20 -78.77 -39.71 -6.09 -10.32 -8.72 -9.82 -32.30 -12.63 -13.90 -19.59 -28.19 -123.66 148.57 115.04 -148.02 -191.97 -137.81 -117.09 135.49 135.494
EV/Revenue 18.52 12.67 6.65 3.85 6.17 4.70 5.65 5.90 4.17 6.08 8.48 12.48 13.49 17.96 14.33 12.70 16.01 11.49 8.76 12.89 12.891
EV/EBIT -72.27 -47.13 -23.76 -5.14 -8.65 -7.15 -8.26 -23.66 -10.42 -12.01 -16.89 -21.56 -62.00 -1524.73 962.01 -72.78 -98.92 -81.84 -71.25 213.60 213.603
EV/FCF -145.69 -114.23 -41.83 -23.45 -38.42 -40.26 -59.49 -80.54 -36.00 -38.03 -47.36 -252.48 205.51 239.09 89.92 84.87 112.16 2656.75 -486.91 -1466.15 -1466.155
Earnings Yield 0.3% -0.5% -1.5% -16.2% -10.8% -17.8% -15.5% -8.7% -17.0% -9.1% -7.5% -7.5% -4.0% -1.6% -1.0% -0.5% -0.3% -1.0% -1.1% 3.6% 3.62%
FCF Yield -0.7% -0.9% -2.3% -4.1% -2.6% -2.4% -1.7% -1.2% -2.8% -2.6% -2.1% -0.4% 0.5% 0.4% 1.0% 1.1% 0.8% 0.0% -0.2% -0.1% -0.06%
Price/Tangible Book snapshot only 6.700
EV/OCF snapshot only 78.533
EV/Gross Profit snapshot only 20.205
Acquirers Multiple snapshot only 177.811
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $14.01
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.65 2.95 3.39 3.55 3.68 3.11 2.81 3.04 2.74 2.86 2.89 2.86 2.78 4.54 4.73 4.43 4.66 5.23 7.30 9.69 9.694
Quick Ratio 2.82 2.28 2.53 2.54 2.76 2.32 1.93 2.05 1.72 1.83 1.77 1.81 1.78 3.66 3.74 3.45 3.64 3.92 5.50 7.14 7.142
Debt/Equity 0.06 0.06 0.05 0.07 0.11 0.12 -0.17 -0.16 0.13 0.10 0.12 0.11 0.12 0.09 0.08 0.07 0.06 0.05 0.04 0.04 0.037
Net Debt/Equity -0.09 -0.09 -0.07 -0.04 -0.04 -0.05 — — 0.01 -0.03 -0.01 0.01 0.02 -0.21 -0.17 -0.17 -0.16 -0.19 -0.18 -0.16 -0.159
Debt/Assets 0.06 0.05 0.05 0.06 0.10 0.10 0.10 0.10 0.11 0.08 0.10 0.10 0.10 0.08 0.07 0.06 0.05 0.04 0.04 0.04 0.035
Debt/EBITDA -2.19 -1.40 -1.12 -0.31 -0.51 -0.50 -0.46 -1.50 -0.92 -0.65 -0.96 -1.03 -4.18 3.82 3.05 -3.63 -3.35 -2.23 -1.99 1.61 1.609
Net Debt/EBITDA 3.11 2.24 1.44 0.19 0.16 0.22 0.15 0.12 -0.07 0.20 0.10 -0.05 -0.54 -9.43 -6.99 8.83 9.44 8.86 8.87 -6.82 -6.816
Interest Coverage -74.52 -74.18 -64.64 -216.26 -332.70 -158.75 -124.53 -32.31 -33.92 -33.58 -31.47 -29.53 -13.96 -1.07 2.06 -88.42 -30.55 -20.46 -18.58 9.40 9.402
Equity Multiplier 1.14 1.15 1.14 1.14 1.19 1.24 -1.71 -1.60 1.24 1.22 1.20 1.17 1.17 1.14 1.12 1.12 1.11 1.09 1.08 1.07 1.065
Cash Ratio snapshot only 5.909
Debt Service Coverage snapshot only 14.821
Cash to Debt snapshot only 5.237
FCF to Debt snapshot only -0.057
Defensive Interval snapshot only 584.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.26 0.30 0.35 0.30 0.30 0.32 0.33 0.36 0.32 0.27 0.23 0.20 0.22 0.16 0.18 0.20 0.19 0.24 0.25 0.25 0.246
Inventory Turnover 2.83 4.08 4.70 3.58 3.41 3.41 3.00 3.00 2.42 1.82 1.27 0.91 0.79 0.27 0.33 0.47 0.54 1.15 1.19 1.18 1.176
Receivables Turnover 7.34 7.63 7.93 5.65 5.88 5.66 5.98 5.58 5.09 4.49 4.04 3.52 4.05 4.69 5.10 5.44 5.15 11.24 8.98 9.93 9.928
Payables Turnover 6.93 8.75 12.30 9.91 7.88 7.12 7.87 9.78 7.42 6.39 5.25 4.38 3.77 1.86 2.83 3.83 4.84 13.48 10.23 13.08 13.081
DSO 50 48 46 65 62 64 61 65 72 81 90 104 90 78 72 67 71 32 41 37 36.8 days
DIO 129 90 78 102 107 107 122 122 151 201 287 401 463 1354 1104 773 672 317 306 310 310.3 days
DPO 53 42 30 37 46 51 46 37 49 57 70 83 97 196 129 95 75 27 36 28 27.9 days
Cash Conversion Cycle 126 96 94 130 123 120 136 150 173 225 308 421 456 1235 1047 745 668 322 311 319 319.1 days
Fixed Asset Turnover snapshot only 4.306
Operating Cycle snapshot only 347.0 days
Cash Velocity snapshot only 1.248
Capital Intensity snapshot only 4.352
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 1.3% 1.5% 1.6% 99.7% 60.3% 35.8% 17.8% 9.7% -6.3% -26.9% -39.4% -51.2% -40.6% -44.7% -28.4% -3.3% -14.1% 47.4% 40.9% 34.4% 34.39%
Net Income -10.8% -4.1% 31.0% -28.1% -23.3% -15.6% -9.1% 12.3% 2.4% 52.1% 56.7% 11.6% 55.0% 69.6% 83.5% 92.5% 93.0% 39.9% -0.8% 10.1% 10.12%
EPS -34.8% -3.5% 45.4% -26.8% -23.6% -15.1% -8.9% 14.3% 4.5% 54.3% 59.0% 16.5% 57.5% 71.6% 84.1% 92.8% 93.4% 40.7% 3.5% 9.8% 9.85%
FCF -6.6% -8.0% -29.6% -85.6% -1.0% -42.8% 29.6% 51.0% 32.4% -0.0% -14.2% 67.1% 1.3% 1.3% 1.6% 3.9% 86.9% -91.5% -1.2% -1.1% -1.08%
EBITDA -11.9% -1.7% -2.3% -11.9% -5.5% -3.5% -3.0% 68.3% 48.3% 40.7% 54.4% -18.3% 80.4% 1.2% 1.2% 81.3% 34.3% -2.0% -1.8% 2.5% 2.49%
Op. Income -9.8% -5.3% -5.5% -3.3% -1.2% -11.7% 8.9% 3.2% -0.4% -13.9% 14.9% 51.2% 66.1% 83.9% 85.5% 22.1% -3.7% -70.2% -1.2% 1.4% 1.41%
OCF Growth snapshot only 8.59%
Asset Growth snapshot only 15.56%
Equity Growth snapshot only 20.98%
Debt Growth snapshot only -33.92%
Shares Change snapshot only 3.13%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 77.0% 82.1% 85.5% 85.4% 84.8% 80.8% 69.1% 63.7% 51.6% 34.9% 23.3% 2.2% -3.8% -18.2% -20.0% -19.7% -21.8% -15.9% -15.1% -14.1% -14.10%
Revenue 5Y 65.4% 70.7% 73.8% 73.9% 72.5% 71.1% 67.3% 60.8% 52.8% 43.0% 35.4% 27.8% 28.5% 19.0% 16.0% 15.7% 12.2% 14.9% 13.6% 6.8% 6.78%
EPS 3Y 12.3% — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — 63.9% 63.89%
Net Income 3Y 37.4% — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — 70.5% 70.55%
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — 21.6% 19.2% — — — — — —
Gross Profit 3Y 49.5% 40.8% 38.3% 37.0% 39.7% 42.7% 36.6% 33.2% 28.2% 19.6% 15.7% 8.5% 13.2% 13.7% 13.7% 14.1% 7.3% 4.9% 4.4% 7.0% 6.99%
Gross Profit 5Y 53.6% 51.2% 50.9% 49.5% 49.4% 51.5% 48.5% 40.5% 34.9% 28.2% 24.3% 23.3% 26.9% 24.6% 21.9% 22.4% 18.6% 17.8% 16.9% 12.5% 12.52%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — 19.9% 55.6% 1.6% 21.3% 36.9% -26.1% — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — 26.6% 47.4% 81.0% 25.3% 42.3% 25.3% 18.5% — —
Assets 3Y 1.3% 1.3% 1.2% 1.1% 79.6% 69.2% 67.5% 56.1% 28.0% 20.7% 18.7% -10.4% -12.0% -10.3% -10.1% -6.3% -7.0% -3.4% -3.5% 1.1% 1.09%
Assets 5Y 1.2% 1.3% 1.3% 1.2% 1.2% 1.1% 1.1% 81.8% 54.7% 55.4% 52.9% 48.6% 35.3% 33.8% 33.0% 27.7% 14.9% 11.6% 10.8% -3.0% -2.99%
Equity 3Y 1.2% 1.2% 1.2% 1.1% 74.4% 63.7% — — 21.1% 18.1% 16.9% -10.8% -12.7% -10.1% -9.7% -5.6% -4.7% 0.7% — — —
Book Value 3Y 82.6% 85.1% 68.5% 72.7% 46.6% 32.9% — — 8.9% 6.6% 5.3% -14.5% -14.6% -14.3% -13.1% -9.2% -8.8% -3.5% — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.73 0.71 0.71 0.78 0.82 0.85 0.85 0.89 0.89 0.74 0.56 0.39 0.38 0.13 0.07 0.03 0.02 0.02 0.02 0.00 0.000
Earnings Stability 0.54 0.01 0.04 0.31 0.35 0.45 0.50 0.62 0.68 0.54 0.54 0.68 0.50 0.22 0.17 0.12 0.04 0.00 0.02 0.22 0.220
Margin Stability 0.80 0.74 0.71 0.70 0.69 0.67 0.67 0.65 0.66 0.65 0.65 0.64 0.63 0.54 0.56 0.58 0.62 0.63 0.67 0.69 0.687
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0
Earnings Persistence 0.96 0.20 0.50 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.95 0.50 0.50 0.50 0.50 0.50 0.84 1.00 0.20 0.200
Earnings Smoothness 0.89 — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.08 -0.09 -0.22 -0.31 -0.28 -0.38 — — -0.18 0.00 — — 0.14 0.23 — — 0.22 0.09 0.08 0.24 0.242
Gross Margin Trend -0.24 -0.31 -0.31 -0.27 -0.19 -0.11 -0.08 -0.06 0.01 0.07 0.14 0.28 0.32 0.49 0.43 0.36 0.27 0.02 -0.01 -0.06 -0.063
FCF Margin Trend -0.20 -0.14 -0.17 -0.13 -0.12 -0.08 -0.02 0.10 0.03 -0.05 -0.05 0.07 0.20 0.21 0.30 0.21 0.17 0.05 -0.01 -0.06 -0.059
Sustainable Growth Rate 1.4% — — — — — — — — — — — — — — — — — — 13.2% 13.15%
Internal Growth Rate 1.3% — — — — — — — — — — — — — — — — — — 13.7% 13.75%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.25 0.58 1.02 0.18 0.17 0.06 0.02 0.01 0.07 0.19 0.23 0.00 -0.20 -0.42 -1.41 -2.81 -5.25 -1.66 -1.71 0.33 0.335
FCF/OCF 10.30 2.73 1.51 1.45 1.43 2.22 4.73 11.02 2.42 1.51 1.24 46.57 0.62 0.58 0.77 0.74 0.63 0.02 -0.10 -0.05 -0.054
FCF/Net Income snapshot only -0.018
OCF/EBITDA snapshot only 1.725
CapEx/Revenue 11.5% 7.0% 5.4% 5.1% 4.8% 6.4% 7.5% 6.7% 6.8% 5.4% 3.5% 4.8% 4.0% 5.4% 4.7% 5.4% 8.5% 20.5% 19.7% 17.3% 17.29%
CapEx/Depreciation snapshot only 4.971
Accruals Ratio 0.02 -0.01 0.00 -0.16 -0.17 -0.26 -0.29 -0.18 -0.21 -0.12 -0.11 -0.18 -0.14 -0.07 -0.06 -0.06 -0.05 -0.08 -0.07 0.08 0.080
Sloan Accruals snapshot only 0.049
Cash Flow Adequacy snapshot only 0.949
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% — — — — — — — — — — — — — — — — — — 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — —
Total Payout Ratio 0.0% — — — — — — — — — — — — — — — — — — 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.0% -0.1% -0.1% -0.1% -0.0% -0.0% -0.0% -0.0% -0.0% -1.5% -1.3% -1.1% -0.9% -0.0% -0.0% -0.0% -0.0% 0.0% -0.0% -0.0% -0.00%
Total Shareholder Return -0.0% -0.1% -0.1% -0.1% -0.0% -0.0% -0.0% -0.0% -0.0% -1.5% -1.3% -1.1% -0.9% -0.0% -0.0% -0.0% -0.0% 0.0% -0.0% -0.0% -0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) -0.29 0.29 0.41 0.89 0.93 0.97 0.97 0.99 1.15 1.26 1.48 1.82 1.74 1.77 1.20 0.34 0.23 1.00 1.01 6.25 6.254
Interest Burden (EBT/EBIT) 0.65 0.90 0.91 0.97 1.02 1.35 1.34 2.07 1.53 0.89 0.86 0.88 1.41 14.86 -8.22 1.22 1.16 0.89 0.85 1.30 1.300
EBIT Margin -0.26 -0.27 -0.28 -0.75 -0.71 -0.66 -0.68 -0.25 -0.40 -0.51 -0.50 -0.58 -0.22 -0.01 0.01 -0.17 -0.16 -0.14 -0.12 0.06 0.060
Asset Turnover 0.26 0.30 0.35 0.30 0.30 0.32 0.33 0.36 0.32 0.27 0.23 0.20 0.22 0.16 0.18 0.20 0.19 0.24 0.25 0.25 0.246
Equity Multiplier 1.12 1.15 1.14 1.15 1.17 1.19 4.55 6.39 1.21 1.23 11.65 15.97 1.21 1.18 1.16 1.14 1.14 1.12 1.10 1.09 1.088
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.11 $-0.20 $-0.34 $-2.23 $-2.46 $-3.24 $-3.38 $-1.91 $-2.35 $-1.48 $-1.39 $-1.60 $-1.00 $-0.42 $-0.22 $-0.12 $-0.07 $-0.25 $-0.21 $1.02 $1.02
Book Value/Share $11.30 $11.54 $11.39 $9.71 $9.57 $8.51 $-6.06 $-6.23 $7.62 $7.53 $7.34 $6.99 $7.05 $7.26 $7.48 $7.26 $7.26 $7.64 $7.56 $8.52 $8.59
Tangible Book/Share $2.55 $2.49 $2.49 $2.62 $2.57 $2.51 $-11.99 $-12.08 $1.96 $2.05 $1.95 $1.68 $1.78 $2.64 $2.79 $2.65 $2.75 $3.27 $3.24 $4.21 $4.21
Revenue/Share $2.23 $2.86 $3.30 $3.48 $3.63 $3.78 $3.79 $3.73 $3.33 $2.64 $2.18 $1.72 $1.86 $1.36 $1.50 $1.60 $1.52 $1.98 $2.03 $2.09 $2.10
FCF/Share $-0.28 $-0.32 $-0.52 $-0.57 $-0.58 $-0.44 $-0.36 $-0.27 $-0.39 $-0.42 $-0.39 $-0.09 $0.12 $0.10 $0.24 $0.24 $0.22 $0.01 $-0.04 $-0.02 $-0.02
OCF/Share $-0.03 $-0.12 $-0.35 $-0.40 $-0.41 $-0.20 $-0.08 $-0.02 $-0.16 $-0.28 $-0.31 $-0.00 $0.20 $0.18 $0.31 $0.33 $0.35 $0.41 $0.36 $0.34 $0.35
Cash/Share $1.74 $1.68 $1.42 $1.10 $1.44 $1.47 $1.32 $1.11 $0.94 $0.99 $1.00 $0.74 $0.74 $2.18 $1.88 $1.71 $1.62 $1.83 $1.64 $1.67 $1.69
EBITDA/Share $-0.33 $-0.46 $-0.55 $-2.20 $-2.17 $-2.04 $-2.18 $-0.68 $-1.10 $-1.15 $-0.94 $-0.76 $-0.20 $0.16 $0.19 $-0.14 $-0.13 $-0.16 $-0.15 $0.20 $0.20
Debt/Share $0.72 $0.64 $0.62 $0.68 $1.10 $1.02 $1.00 $1.03 $1.01 $0.75 $0.90 $0.78 $0.85 $0.63 $0.57 $0.50 $0.42 $0.37 $0.30 $0.32 $0.32
Net Debt/Share $-1.02 $-1.03 $-0.80 $-0.42 $-0.35 $-0.44 $-0.32 $-0.08 $0.07 $-0.23 $-0.10 $0.04 $0.11 $-1.55 $-1.31 $-1.21 $-1.20 $-1.46 $-1.34 $-1.35 $-1.35
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 30.065
Altman Z-Prime snapshot only 52.903
Piotroski F-Score 2 2 3 3 5 4 3 3 3 4 4 4 6 5 5 5 5 6 5 6 6
Beneish M-Score 0.78 0.47 -0.58 -2.87 -3.03 -3.79 -3.99 -3.51 -4.01 -3.73 -3.56 -3.84 -3.39 — -3.07 -2.99 -3.05 — -2.42 -1.99 -1.991
Ohlson O-Score snapshot only -11.348
ROIC (Greenblatt) snapshot only 4.28%
Net-Net WC snapshot only $2.18
EVA snapshot only $11285958.22
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AA-
Credit Score 56.78 56.38 58.14 59.23 59.63 60.60 20.00 20.00 56.59 59.00 59.59 58.94 63.99 61.14 74.05 68.81 67.67 65.49 64.64 84.49 84.488
Credit Grade snapshot only 4
Credit Trend snapshot only 15.675
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 72
Sector Credit Rank snapshot only 82

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms